Literature DB >> 12112935

Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives.

P Sytze van Dam1.   

Abstract

Increased oxidative stress is a mechanism that probably plays a major role in the development of diabetic complications, including peripheral neuropathy. This review summarises recent data from in vitro and in vivo studies that have been performed both to understand this aspect of the pathophysiology of diabetic neuropathy and to develop therapeutic modalities for its prevention or treatment. Extensive animal studies have demonstrated that oxidative stress may be a final common pathway in the development of diabetic neuropathy, and that antioxidants can prevent or reverse hyperglycaemia-induced nerve dysfunction. Most probably, the effects of antioxidants are mediated by correction of nutritive blood flow, although direct effects on endoneurial oxidative state are not excluded. In a limited number of clinical studies, antioxidant drugs including alpha-lipoic acid and vitamin E were found to reduce neuropathic symptoms or to correct nerve conduction velocity. These data are promising, and additional larger studies with alpha-lipoic acid are currently being performed. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112935     DOI: 10.1002/dmrr.287

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  36 in total

1.  Effect of mitoquinone (Mito-Q) on neuropathic endpoints in an obese and type 2 diabetic rat model.

Authors:  Brian Fink; Lawrence Coppey; Eric Davidson; Hanna Shevalye; Alexander Obrosov; Pratik Rajesh Chheda; Robert Kerns; William Sivitz; Mark Yorek
Journal:  Free Radic Res       Date:  2020-04-24

2.  Chronic oral pelargonidin alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: involvement of oxidative stress.

Authors:  Mohammadali Mirshekar; Mehrdad Roghani; Mohsen Khalili; Tourandokht Baluchnejadmojarad; Saiedeh Arab Moazzen
Journal:  Iran Biomed J       Date:  2010 Jan-Apr

3.  Comparison of peripheral nerve protection between insulin-based glucose control and alpha lipoic acid (ALA) in the streptozotocin (STZ)-induced diabetic rat.

Authors:  Kyung Ae Lee; Na Young Lee; Tae Sun Park; Heung Yong Jin
Journal:  Endocrine       Date:  2018-05-07       Impact factor: 3.633

4.  Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2/HO-1/NF-kB and COX signalling pathway.

Authors:  Ruchika Mittal; Anil Kumar; Dhirendra Pratap Singh; Mahendra Bishnoi; Tapas Chandra Nag
Journal:  Inflammopharmacology       Date:  2017-11-01       Impact factor: 4.473

5.  Effect of tempol on peripheral neuropathy in diet-induced obese and high-fat fed/low-dose streptozotocin-treated C57Bl6/J mice.

Authors:  Alexander Obrosov; Hanna Shevalye; Lawrence J Coppey; Mark A Yorek
Journal:  Free Radic Res       Date:  2017-04-19

6.  Protein Mediated Oxidative Stress in Patients with Diabetes and its Associated Neuropathy: Correlation with Protein Carbonylation and Disease Activity Markers.

Authors:  Ebtehal Almogbel; Naila Rasheed
Journal:  J Clin Diagn Res       Date:  2017-02-01

Review 7.  Diabetic neuropathy: clinical features, etiology, and therapy.

Authors:  David Podwall; Clifton Gooch
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

8.  A brief review of in vitro models of diabetic neuropathy.

Authors:  Namita G Hattangady; Medha S Rajadhyaksha
Journal:  Int J Diabetes Dev Ctries       Date:  2009-10

9.  Alpha-lipoic Acid and diabetic neuropathy.

Authors:  Natalia Vallianou; Angelos Evangelopoulos; Pavlos Koutalas
Journal:  Rev Diabet Stud       Date:  2009-12-30

Review 10.  Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.

Authors:  Mark A Yorek
Journal:  Rev Diabet Stud       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.